Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Lidocaine Infusion on NETosis in Robot-assisted Prostatectomy
NCT04840511Active, not recruiting
- Sponsor
- The Catholic University of Korea
- Start
- Sep 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in prostate cancer (PCa) (2 arms), sponsored by The Catholic University of Korea. Primary endpoint: Concentration of citrullinated histone3. Started Sep 2021; status: active, not recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04840511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04840511.